Literature DB >> 16382785

Pathology of pure hippocampal sclerosis in a patient with dementia and Hodgkin's disease: the Ophelia syndrome.

Toshiya Shinohara1, Hideaki Kojima, Nishio Nakamura, Akihiko Ogata, Tomoko Betsuyaku, Akihiko Suzuki, Youichi Maki, Kazuo Nagashima.   

Abstract

An archive autopsy case of a 50-year-old man who died of Hodgkin's lymphoma had a 4-year, 4-month history of dementia. After radiochemotherapy, the lymphoma subsided except for involvement of the spleen, but the dementia remained. Neuropathological examination revealed that the pathology was confined to the hippocampus, both hippocampi showing sclerosis without inflammation. Neurons of sector cornu ammonis (CA) 1 were completely lost whereas moderate neuron loss was also observed in sectors CA3 and 4, and the dentate gyrus. Neurons of sector CA2 were relatively well preserved and the subiculum was intact. There was no evidence of global hypoxia, or of neurodegenerative disorders with pathological changes affecting the hippocampus. Although there was a long preneoplastic history, and no inflammatory changes were found at autopsy, the present case of hippocampal sclerosis could be included in the category of paraneoplastic limbic encephalitis associated with Hodgkin's lymphoma or the Ophelia syndrome.

Entities:  

Mesh:

Year:  2005        PMID: 16382785     DOI: 10.1111/j.1440-1789.2005.00622.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  3 in total

Review 1.  Neuropsychological symptoms in paraneoplastic disorders.

Authors:  Raymond Voltz
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

2.  Current approaches to the treatment of paraneoplastic encephalitis.

Authors:  Wolfgang Grisold; Bruno Giometto; Roberta Vitaliani; Stefan Oberndorfer
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

Review 3.  Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas.

Authors:  Francesc Graus; Helena Ariño; Josep Dalmau
Journal:  Blood       Date:  2014-04-04       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.